![Ronit Satchi-Fainaro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 4 M $ as of 30/05/2026
Ronit Satchi-Fainaro is an Independent Director at Teva Pharmaceutical Industries Ltd. since 2018.
The Director-Biology Research Center at Tel-Aviv University since 2020.
Director at The Israel Cancer Association, Blavatnik Center For Drug Discovery, and Vall D’Hebron University Hospital.
Advisory Board Member at The Energy Federation, Inc. since 2018.
Advisor at Van Leer Xenia Ventures.
Member of 8400 - The Health Network since 2020.
Former President of The Controlled Release Society from 2010 to 2014.
Education includes a doctorate from the University of London conferred in 1999 and an undergraduate degree from The Hebrew University of Jerusalem conferred in 1995.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2026 | 112,401 ( 0.01% ) | 4 M $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Director/Board Member | 31/05/2018 |
The Israel Cancer Association | Director/Board Member | - |
Blavatnik Center For Drug Discovery | Director/Board Member | - |
Vall D’Hebron University Hospital
 Vall D’Hebron University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | - |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/2005 |
8400 - The Health Network | Director/Board Member | 31/12/2019 |
The Energy Federation, Inc.
 The Energy Federation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides energy efficiency technology solutions | Consultant / Advisor | 01/10/2018 |
Van Leer Xenia Ventures
 Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures in companies located in Israel. The firm targets companies operating in the fields of data driven biotechnology and digital pharma. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.7- 1 million. It also makes follow on investments. | Consultant / Advisor | - |
| Companies | Position | End |
|---|---|---|
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services Provides fundamental delivery research, development, regulatory science and clinical translation | Corporate Officer/Principal | 31/12/2013 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services Provides fundamental delivery research, development, regulatory science and clinical translation | Commercial Services |
The Energy Federation, Inc.
The Energy Federation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides energy efficiency technology solutions | Commercial Services |
The Israel Cancer Association | Commercial Services |
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures in companies located in Israel. The firm targets companies operating in the fields of data driven biotechnology and digital pharma. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.7- 1 million. It also makes follow on investments. | Finance |
Blavatnik Center For Drug Discovery | Commercial Services |
Vall D’Hebron University Hospital
Vall D’Hebron University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
8400 - The Health Network | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
